Does COVID-19 impair V̇o 2peak in patients with cardiorespiratory disease? Insight from cardiopulmonary responses to maximal exercise pre- and post-illness.

MLA

Fernandes, Igor A., et al. “Does COVID-19 Impair V̇o 2peak in Patients with Cardiorespiratory Disease? Insight from Cardiopulmonary Responses to Maximal Exercise Pre- and Post-Illness.” Journal of Applied Physiology (Bethesda, Md. : 1985), vol. 135, no. 5, Nov. 2023, pp. 1146–56. EBSCOhost, https://doi.org/10.1152/japplphysiol.00357.2023.

APA

Fernandes, I. A., Balavenkataraman, A., Bonvie-Hill, N. E., Patel, N. M., Taylor, B. J., & Helgeson, S. A. (2023). Does COVID-19 impair V̇o 2peak in patients with cardiorespiratory disease? Insight from cardiopulmonary responses to maximal exercise pre- and post-illness. Journal of Applied Physiology (Bethesda, Md. : 1985), 135(5), 1146–1156. https://doi.org/10.1152/japplphysiol.00357.2023

Chicago

Fernandes, Igor A, Arvind Balavenkataraman, Natalie E Bonvie-Hill, Neal M Patel, Bryan J Taylor, and Scott A Helgeson. 2023. “Does COVID-19 Impair V̇o 2peak in Patients with Cardiorespiratory Disease? Insight from Cardiopulmonary Responses to Maximal Exercise Pre- and Post-Illness.” Journal of Applied Physiology (Bethesda, Md. : 1985) 135 (5): 1146–56. doi:10.1152/japplphysiol.00357.2023.